130 related articles for article (PubMed ID: 2173018)
1. Pharmacology of migraine.
Raskin NH
Prog Drug Res; 1990; 34():209-30. PubMed ID: 2173018
[TBL] [Abstract][Full Text] [Related]
2. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
3. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
Peroutka SJ
Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
[TBL] [Abstract][Full Text] [Related]
4. The biology of serotonin receptors: focus on migraine pathophysiology and treatment.
Hamel E
Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S2-6. PubMed ID: 10563226
[TBL] [Abstract][Full Text] [Related]
5. Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers.
de Montigny C; Chaput Y; Blier P
J Clin Psychiatry; 1990 Dec; 51 Suppl B():4-8. PubMed ID: 2175309
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological and histochemical properties of postnatal rat serotonergic neurons in dissociated cell culture.
Johnson MD
Neuroscience; 1994 Dec; 63(3):775-87. PubMed ID: 7898677
[TBL] [Abstract][Full Text] [Related]
7. New insights into the molecular actions of serotonergic antimigraine drugs.
Durham PL; Russo AF
Pharmacol Ther; 2002; 94(1-2):77-92. PubMed ID: 12191595
[TBL] [Abstract][Full Text] [Related]
8. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L
Encephale; 1995; 21(2):123-32. PubMed ID: 7781583
[TBL] [Abstract][Full Text] [Related]
9. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
[TBL] [Abstract][Full Text] [Related]
10. [The role of agonists of serotonin receptor 5HT1B/D in pathogenesis and treatment of migraine attacks].
Stepień A
Pol Merkur Lekarski; 1999 Jun; 6(36):341-3. PubMed ID: 10481551
[TBL] [Abstract][Full Text] [Related]
11. Migraine: pathophysiology, pharmacology, treatment and future trends.
Villalón CM; Centurión D; Valdivia LF; de Vries P; Saxena PR
Curr Vasc Pharmacol; 2003 Mar; 1(1):71-84. PubMed ID: 15320857
[TBL] [Abstract][Full Text] [Related]
12. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
[TBL] [Abstract][Full Text] [Related]
13. Migraine: current therapeutic targets and future avenues.
Arulmozhi DK; Veeranjaneyulu A; Bodhankar SL
Curr Vasc Pharmacol; 2006 Apr; 4(2):117-28. PubMed ID: 16611154
[TBL] [Abstract][Full Text] [Related]
14. [Migraine, serotonin and serotonergic receptors].
Pascual J
Neurologia; 1993; 8(6):180-3. PubMed ID: 8394726
[No Abstract] [Full Text] [Related]
15. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
Ogren SO; Kuteeva E; Hökfelt T; Kehr J
CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
[TBL] [Abstract][Full Text] [Related]
16. Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission.
Haddjeri N; Blier P
Biol Psychiatry; 2001 Aug; 50(3):191-9. PubMed ID: 11513818
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP mediates circadian phase shifts induced by microinjection of serotonergic drugs in the hamster dorsal raphe nucleus.
Duncan MJ; Davis VA
Brain Res; 2005 Oct; 1058(1-2):10-6. PubMed ID: 16150426
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine.
Peroutka SJ
Neurology; 1993 Jun; 43(6 Suppl 3):S34-8. PubMed ID: 8389009
[TBL] [Abstract][Full Text] [Related]
19. Is a central action of acute antimigraine drugs essential?
Goadsby PJ
Cephalalgia; 1997 Jun; 17 Suppl 17():10-1. PubMed ID: 9218879
[No Abstract] [Full Text] [Related]
20. Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target?
Shields KG; Goadsby PJ
Neurobiol Dis; 2006 Sep; 23(3):491-501. PubMed ID: 16875831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
